3:48
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
José Felipe Varona, Pedro Landete, Roger Paredes, Roberto Vates, Miguel Torralba, Pablo Guisado‐Vasco, Lourdes Porras, Patricia Muñóz, Paloma Gijón, Julio Ancochea, Elena María Saiz, Fernanda Salazar Meira, José María Jimeno, Jose Antonio Lopez-Martin, Vicente Estrada
COVID-19 can end in the hospital and still keep changing a person’s life months later. This follow-up asks whether people treated with plitidepsin remained well over the longer term. A COVID-19 treatment was followed up more than a year later, not just for survival, but for lingering harm. In this small extension study, most measured long-term findings were reassuring, but the evidence has important limits.
